Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, Amgen Inc. reported revenue of $36.75B, up 10.0% year over year. Operating margin was 24.7% and net margin 21.0%, on a free-cash-flow margin of 22.0% with capital expenditure at 5.1% of revenue. Every figure is computed directly from AMGN's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $36.75B | 24.7% | 21.0% |
| FY2024 | $33.42B | 21.7% | 12.2% |
| FY2023 | $28.19B | 28.0% | 23.8% |
| FY2022 | $26.32B | 36.3% | 24.9% |
| FY2021 | $25.98B | 29.4% | 22.7% |
How does AMGN compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAWH · ABBV · ABCL · ABT · ABUS · ACAD
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.